Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer

NCT01727076 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01727076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01727076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
February 15, 2013
Completion date
June 30, 2016
Enrollment
20 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma, recurrent head and neck carcinoma, recurrent non-small cell lung carcinoma, recurrent renal cell carcinoma, recurrent skin carcinoma, stage iii renal cell cancer, stage iiia cutaneous melanoma ajcc v7, stage iiia non-small cell lung cancer ajcc v7, stage iiib cutaneous melanoma ajcc v7, stage iiib non-small cell lung cancer ajcc v7, stage iiic cutaneous melanoma ajcc v7, stage iv cutaneous melanoma ajcc v6 and v7, stage iv non-small cell lung cancer ajcc v7, stage iv renal cell cancer